5-80675095-CAAAA-CAAAAA
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_002439.5(MSH3):c.1148dupA(p.Asn385GlnfsTer19) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000754 in 1,459,408 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. K383K) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002439.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- familial adenomatous polyposis 4Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
- MSH3-related attenuated familial adenomatous polyposisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Lynch syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002439.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MSH3 | NM_002439.5 | MANE Select | c.1148dupA | p.Asn385GlnfsTer19 | frameshift | Exon 7 of 24 | NP_002430.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MSH3 | ENST00000265081.7 | TSL:1 MANE Select | c.1148dupA | p.Asn385GlnfsTer19 | frameshift | Exon 7 of 24 | ENSP00000265081.6 | ||
| MSH3 | ENST00000658259.1 | c.980dupA | p.Asn329GlnfsTer19 | frameshift | Exon 7 of 24 | ENSP00000499617.1 | |||
| MSH3 | ENST00000667069.1 | c.1148dupA | p.Asn385GlnfsTer19 | frameshift | Exon 7 of 22 | ENSP00000499502.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 248208 AF XY: 0.00000745 show subpopulations
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1459408Hom.: 0 Cov.: 31 AF XY: 0.00000964 AC XY: 7AN XY: 726118 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
The MSH3 c.1148dup (p.Asn385Glnfs*19) variant alters the translational reading frame of the MSH3 mRNA and is predicted to cause the premature termination of MSH3 protein synthesis. This variant has not been reported in individuals with MSH3-related conditions in the published literature. The frequency of this variant in the general population, 0.000004 (1/248208 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Based on the available information, this variant is classified as likely pathogenic.
This sequence change creates a premature translational stop signal (p.Asn385Glnfs*19) in the MSH3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH3 are known to be pathogenic (PMID: 27476653, 37402566). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with MSH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 643621). RNA analysis performed to evaluate the impact of this premature translational stop signal on mRNA splicing indicates it does not significantly alter splicing (internal data). For these reasons, this variant has been classified as Pathogenic.
MSH3: PVS1, PM2
Familial adenomatous polyposis 4 Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1148dupA pathogenic mutation, located in coding exon 7 of the MSH3 gene, results from a duplication of A at nucleotide position 1148, causing a translational frameshift with a predicted alternate stop codon (p.N385Qfs*19). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Endometrial carcinoma;C4310719:Familial adenomatous polyposis 4 Pathogenic:1
Endometrial carcinoma Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at